Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia

OBJECTIVE: Preterm infants are at a high risk of developing BPD. Although progression in neonatal care has improved, BPD still causes significant morbidity and mortality, which can be attributed to the limited therapeutic choices for BPD. This review discusses the potential of MSC in treating BPD as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Eireen, Zaidi, Mariam, Lim, Wen‐Huey, Govindasamy, Vijayendran, Then, Kong‐Yong, Then, Khong‐Lek, Das, Anjan Kumar, Cheong, Soon‐Keng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527154/
https://www.ncbi.nlm.nih.gov/pubmed/36055758
http://dx.doi.org/10.1111/crj.13540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527154/
https://www.ncbi.nlm.nih.gov/pubmed/36055758
http://dx.doi.org/10.1111/crj.13540

Ejemplares similares